• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

High risk of the critically ill for venous thromboembolism.

作者信息

Cade J F

出版信息

Crit Care Med. 1982 Jul;10(7):448-50. doi: 10.1097/00003246-198207000-00006.

DOI:10.1097/00003246-198207000-00006
PMID:7044682
Abstract

The incidence of deep venous thrombosis of the legs (DVT) was studied in 119 critically ill patients by 125I-labeled fibrinogen scanning; the efficacy of low-dose heparin prophylaxis was assessed in a randomized, double-blind study. DVT occurred in 29% of control patients and in 13% of patients receiving heparin 5000 U subcutaneously twice daily. DVT was found mainly in men and was associated with circulatory impairment, respiratory failure and recent vascular or cancer surgery. In a comparison study of medical patients, DVT occurred in 10% untreated and 2% treated. In conclusion, the critically ill are at high risk of venous thromboembolism and low-dose prophylaxis is warranted in those who have no hemostatic impairment.

摘要

相似文献

1
High risk of the critically ill for venous thromboembolism.
Crit Care Med. 1982 Jul;10(7):448-50. doi: 10.1097/00003246-198207000-00006.
2
Prophylaxis of venous thrombosis after major thoracic surgery.胸科大手术后静脉血栓形成的预防
Aust N Z J Surg. 1983 Aug;53(4):301-4. doi: 10.1111/j.1445-2197.1983.tb02451.x.
3
Low dose heparin and compression stockings in the prevention of postoperative deep venous thrombosis.
Br J Surg. 1980 Jul;67(7):482-4. doi: 10.1002/bjs.1800670710.
4
Postoperative deep venous thrombosis and infectious complications. A clinical study of patients undergoing colo-rectal surgery.术后深静脉血栓形成与感染性并发症。一项关于接受结直肠手术患者的临床研究。
Scand J Infect Dis. 1980;12(2):123-7. doi: 10.3109/inf.1980.12.issue-2.09.
5
A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.低分子量肝素与双氢麦角胺固定剂量组合对比调整剂量普通肝素预防全髋关节置换术后深静脉血栓形成的研究
Thromb Haemost. 1996 Feb;75(2):246-50.
6
A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis.一种用于预防术后深静脉血栓形成的低分子量肝素(凯比2165)。
Acta Chir Scand. 1986 Oct;152:593-6.
7
Rates of venous thrombosis after general surgery: combined results of randomised clinical trials.普通外科手术后静脉血栓形成的发生率:随机临床试验的综合结果。
Lancet. 1986 Jul 19;2(8499):143-6. doi: 10.1016/s0140-6736(86)91955-0.
8
Prevention of postoperative thromboembolism by dextran 70 or low-dose heparin.右旋糖酐70或低剂量肝素预防术后血栓栓塞
Obstet Gynecol. 1980 Apr;55(4):497-500.
9
Concentrated or diluted heparin prophylaxis of postoperative deep venous thrombosis.浓缩或稀释肝素预防术后深静脉血栓形成。
Acta Chir Scand. 1978;144(5):283-8.
10
Prevention of postoperative deep-vein thrombosis by low-dose heparin in open prostatectomy.低剂量肝素预防开放性前列腺切除术后深静脉血栓形成
Urol Res. 1980;8(4):219-21. doi: 10.1007/BF00256997.

引用本文的文献

1
A systematic review on post-discharge venous thromboembolism prophylaxis in patients with COVID-19.关于新冠病毒病患者出院后静脉血栓栓塞预防的系统评价
Egypt Heart J. 2023 Aug 18;75(1):72. doi: 10.1186/s43044-023-00400-2.
2
Chemical versus Mechanical and Chemical Venous Thromboembolism Prophylaxis in Neurocritically Ill Patients: A Cohort Study.神经重症患者中化学抗凝与机械及化学联合抗凝预防静脉血栓栓塞的队列研究
Clin Pharmacol. 2023 Jan 7;15:1-8. doi: 10.2147/CPAA.S388950. eCollection 2023.
3
Incidence of COVID-19-Associated Venous Thromboembolism Among Hospitalized Patients in McAllen, Texas, USA, in Late 2021.
2021年末美国得克萨斯州麦卡伦市住院患者中与新冠病毒疾病相关的静脉血栓栓塞症发病率
Cureus. 2022 Mar 17;14(3):e23270. doi: 10.7759/cureus.23270. eCollection 2022 Mar.
4
Incidence of proximal deep vein thrombosis in medical critical care patients.内科重症监护患者近端深静脉血栓形成的发生率。
Thromb J. 2022 Feb 5;20(1):5. doi: 10.1186/s12959-022-00363-5.
5
Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study.中国浙江省危重症患者深静脉血栓形成的预防、治疗和危险因素:一项多中心、前瞻性、观察性研究。
Ann Med. 2021 Dec;53(1):2234-2245. doi: 10.1080/07853890.2021.2005822.
6
Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis.新冠肺炎重症患者发生临床相关静脉血栓栓塞症的风险:一项系统评价和荟萃分析
Front Med (Lausanne). 2021 Mar 9;8:647917. doi: 10.3389/fmed.2021.647917. eCollection 2021.
7
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.美国血液学会 2021 年静脉血栓栓塞症管理指南:癌症患者的预防和治疗。
Blood Adv. 2021 Feb 23;5(4):927-974. doi: 10.1182/bloodadvances.2020003442.
8
Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis.接受血栓预防的COVID-19住院患者的静脉血栓栓塞:一项系统评价和荟萃分析
J Clin Med. 2020 Aug 3;9(8):2489. doi: 10.3390/jcm9082489.
9
Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.血栓预防:在 COVID-19 大流行期间平衡证据和经验。
J Thromb Thrombolysis. 2020 Nov;50(4):799-808. doi: 10.1007/s11239-020-02231-3.
10
Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?血管性血友病因子(vWF):COVID-19 中内皮损伤和血栓形成风险的标志物?
Clin Med (Lond). 2020 Sep;20(5):e178-e182. doi: 10.7861/clinmed.2020-0346. Epub 2020 Jul 21.